Nerve growth factor (NGF) mediates the survival and differentiation of neurons by stimulating the tyrosine kinase activity of the TrkA/NGF receptor. Here, we identify SHP-1 as a phosphotyrosine phosphatase that negatively regulates TrkA. SHP-1 formed complexes with TrkA at Y490, and dephosphorylated it at Y674/675. Expression of SHP-1 in sympathetic neurons induced apoptosis and TrkA dephosphorylation. Conversely, inhibition of endogenous SHP-1 with a dominant-inhibitory mutant stimulated basal tyrosine phosphorylation of TrkA, thereby promoting NGF-independent survival and causing sustained and elevated TrkA activation in the presence of NGF. Mice lacking SHP-1 had increased numbers of sympathetic neurons during the period of naturally occurring neuronal cell death, and when cultured, these neurons survived better than wild-type neurons in the absence of NGF. These data indicate that SHP-1 can function as a TrkA phosphatase, controlling both the basal and NGF-regulated level of TrkA activity in neurons, and suggest that SHP-1 regulates neuron number during the developmental cell death period by directly regulating TrkA activity.
Skip Nav Destination
Article navigation
8 December 2003
Article Contents
Article|
December 08 2003
SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase
H. Nicholas Marsh,
H. Nicholas Marsh
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
Search for other works by this author on:
Catherine I. Dubreuil,
Catherine I. Dubreuil
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
Search for other works by this author on:
Celia Quevedo,
Celia Quevedo
2Cancer Research Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
Search for other works by this author on:
Anna Lee,
Anna Lee
3Developmental Biology Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
Search for other works by this author on:
Marta Majdan,
Marta Majdan
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
Search for other works by this author on:
Gregory S. Walsh,
Gregory S. Walsh
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
3Developmental Biology Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
Search for other works by this author on:
Sharon Hausdorff,
Sharon Hausdorff
4Cancer Biology Program, Division of Medicine, Harvard Medical School, Beth Israel Hospital, Boston, MA 02215
Search for other works by this author on:
Farid Arab Said,
Farid Arab Said
5Aegera Therapeutics, Inc., Montreal, Quebec H3E 1A8, Canada
Search for other works by this author on:
Olga Zoueva,
Olga Zoueva
6Health Canada, Biologics and Genetics Therapies Directorate, Center for Biologics Research, Ottawa, Ontario K1A 0L2, Canada
Search for other works by this author on:
Maya Kozlowski,
Maya Kozlowski
6Health Canada, Biologics and Genetics Therapies Directorate, Center for Biologics Research, Ottawa, Ontario K1A 0L2, Canada
Search for other works by this author on:
Katherine Siminovitch,
Katherine Siminovitch
7Department of Medicine, University of Toronto, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Search for other works by this author on:
Benjamin G. Neel,
Benjamin G. Neel
4Cancer Biology Program, Division of Medicine, Harvard Medical School, Beth Israel Hospital, Boston, MA 02215
Search for other works by this author on:
Freda D. Miller,
Freda D. Miller
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
3Developmental Biology Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
8Department of Medical Genetics and Microbiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Search for other works by this author on:
David R. Kaplan
David R. Kaplan
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
2Cancer Research Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
8Department of Medical Genetics and Microbiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Search for other works by this author on:
H. Nicholas Marsh
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
Catherine I. Dubreuil
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
Celia Quevedo
2Cancer Research Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
Anna Lee
3Developmental Biology Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
Marta Majdan
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
Gregory S. Walsh
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
3Developmental Biology Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
Sharon Hausdorff
4Cancer Biology Program, Division of Medicine, Harvard Medical School, Beth Israel Hospital, Boston, MA 02215
Farid Arab Said
5Aegera Therapeutics, Inc., Montreal, Quebec H3E 1A8, Canada
Olga Zoueva
6Health Canada, Biologics and Genetics Therapies Directorate, Center for Biologics Research, Ottawa, Ontario K1A 0L2, Canada
Maya Kozlowski
6Health Canada, Biologics and Genetics Therapies Directorate, Center for Biologics Research, Ottawa, Ontario K1A 0L2, Canada
Katherine Siminovitch
7Department of Medicine, University of Toronto, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Benjamin G. Neel
4Cancer Biology Program, Division of Medicine, Harvard Medical School, Beth Israel Hospital, Boston, MA 02215
Freda D. Miller
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
3Developmental Biology Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
8Department of Medical Genetics and Microbiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
David R. Kaplan
1Brain Tumor Research Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada
2Cancer Research Program, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
8Department of Medical Genetics and Microbiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Address correspondence to D. Kaplan, Cancer Research Program, Hospital for Sick Children, 555 University Ave., Toronto, Ontario, M5G 1X8. Tel.: (416) 813-7654, ext. 1433. Fax: (416) 813-2212. email: [email protected]
C.I. Dubreuil and C. Quevedo contributed equally to this work.
H.N. Marsh's present address is Archemix Corporation, 1 Hampshire St., Cambridge, MA 02139.
Abbreviations used in this paper: Ad, adenovirus; MOI, multiplicity of infection; P, postnatal day; SCG, superior cervical ganglia; wt, wild-type.
Received:
September 05 2003
Accepted:
October 13 2003
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2003
J Cell Biol (2003) 163 (5): 999–1010.
Article history
Received:
September 05 2003
Accepted:
October 13 2003
Citation
H. Nicholas Marsh, Catherine I. Dubreuil, Celia Quevedo, Anna Lee, Marta Majdan, Gregory S. Walsh, Sharon Hausdorff, Farid Arab Said, Olga Zoueva, Maya Kozlowski, Katherine Siminovitch, Benjamin G. Neel, Freda D. Miller, David R. Kaplan; SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase . J Cell Biol 8 December 2003; 163 (5): 999–1010. doi: https://doi.org/10.1083/jcb.200309036
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
